Affymax (AFFY) News Today → My top 100 stocks… (From DTI) (Ad) Free AFFY Stock Alerts $0.0007 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartFinancialsShort InterestStock AnalysisChartFinancialsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineFull Glass Wine Co. Secures $14 Million Funding; Acquires Leading DTC Wine Subscription Brand, Bright Cellarsfinance.yahoo.com - April 4 at 3:48 PMNested Therapeutics Strengthens Board of Directors with Appointment of New Chair and Directorsfinance.yahoo.com - February 27 at 10:13 AMAffymax Stock (OTC:AFFY), Short Interest Reportbenzinga.com - February 23 at 10:59 AMJasper Therapeutics Appoints Herb Cross as Chief Financial Officerfinance.yahoo.com - September 25 at 8:18 AMAnaptysBio Announces Appointment of John Orwin as Chairman of the Board of Directorsmarkets.businessinsider.com - September 18 at 8:48 PM4 Biotech Stocks Under $5 to Watchthestreet.com - June 7 at 1:49 AM10 Biotech Stocks on Clinical Trials Watchthestreet.com - May 15 at 10:14 AMWhy a UCSF vice chancellor is returning to the biotech industrybizjournals.com - January 19 at 3:44 PMHinge Bio Expands Senior Management Team to Drive GEM-DIMER(TM) Programs to Clinical Developmentmarketwatch.com - January 18 at 7:43 PMHinge Bio Expands Senior Management Team to Drive GEM-DIMER™ Programs to Clinical Developmentnz.finance.yahoo.com - January 18 at 9:42 AMTurn Biotechnologies, Inc.: Turn Biotechnologies launches eTurna delivery platform designed specifically to enable nucleic acid therapeuticsfinanznachrichten.de - September 14 at 9:36 PMAFFY.PK - Affymax, Inc. | Stock Price & Latest News | Reutersreuters.com - August 28 at 8:55 PMFrontier Medicines Announces the Appointment of Seasoned Legal Executive Mark Dizon, J.D., as General Counselfinance.yahoo.com - August 25 at 10:26 AMEsso Thailand PCL F (ESSOf)investing.com - August 3 at 9:45 PMDialog Group Bhd (DIAL)investing.com - August 3 at 9:45 PMDPS Resources Bhd (DPSS)investing.com - July 30 at 8:02 AMRenal Disease Treatment Market Size with New Growth Prospect By Top Key Players | Impact of COVID-19 Pandemicmarketwatch.com - April 27 at 10:34 AMRenal Disease Treatment Market Scope with New Growth Prospect By Top Key Players | Impact of COVID-19 Pandemicmarketwatch.com - March 27 at 10:14 PMArcutis Announces Appointment of Keith Leonard to Board of Directorsca.finance.yahoo.com - September 2 at 6:05 PM Get Affymax News Delivered to You Automatically Sign up to receive the latest news and ratings for AFFY and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now AFFY Media Mentions By Week AFFY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AFFY News Sentiment▼0.000.33▲Average Medical News Sentiment AFFY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AFFY Articles This Week▼00▲AFFY Articles Average Week Get Affymax News Delivered to You Automatically Sign up to receive the latest news and ratings for AFFY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Bayer Aktiengesellschaft News Today Capstone News Today Context Therapeutics News Today EOM Pharmaceuticals News Today Genmab A/S News Today Grifols News Today Hypera News Today International Stem Cell News Today LAVA Therapeutics News Today Mainz Biomed News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:AFFY) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressThe only accurate crypto trading system I know …Weiss RatingsThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Affymax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
